Inventiva S.A. ADR (IVA) Social Stream



Inventiva S.A. ADR (IVA): $13.60

0.43 (+3.26%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Featured Post From StockTwits About IVA

$IVA, a company developing Lanifibranor, a drug addressing Nonalcoholic steatohepatitis (NASH), will present the P2B data on June 25th at the EASL International Liver Congress.

The stock has been range bound between +3 & -1Σ. The company topped at $19 last January, but has not broken its upward momentum. We have bounced off -1Σ and completed the x̄ reversal.

Due to a lack of volume, the TTM is kind of irrelevant. Nevertheless, there's been some crowd loading in the $12-16/share zone per volume profile.

This company has a float of 10.29M (not sure if FINVIZ data is up to date) with 150k shares being held short.

IMPORTANT: there are a whole bunch of 6-k filings on EDGAR. The management is diluting. That being said, the float remains significantly small that a MASSIVE move like ORPH is possible.

A swing long towards +2Σ or +3Σ gives us $4-$6 upside potential:

Entry: 14.5-13.5
Stop: 12.2
Exit: 18.83-20.57

Source: https://ml-eu.globenewswire.com/Resource/Download/510a477e-4f73-435e-8934-d3b18069be4b
Tain0os, published June 17, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4956 seconds.